- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01433692
CANABIC : CANnabis and Adolescents, a Brief Intervention (BI) to Reduce Their Consumption (CANABIC)
Does a BI Conducted by General Practitioners Reduce Consumption of Canabis in 15 to 25 Years Old ?
Background: Cannabis is the most prevalent illegal drug used in France, and consequences arising from the step of 'casual consumers'(1-10 joints/month). Side effects of cannabis are now well documented: Trauma (driving after consuming cannabis), respiratory, cardiovascular diseases and psychiatric and social problems. The general practitioner (GP) is the health professional most viewed by adolescents. Brief interventions (BI) for adult alcohol use have been shown to be efficient. Some BI have been designed to inspect adolescents and consumption of cannabis have been piloted, showing their feasibility, but no test has validated them.
Aim : Does a BI conducted by general practitioners reduce consumption of canabis in 15 to 19 years old ?
Method:
Two preliminary qualitative studies (with adolescents and GP), were used to analyze the difficulties of communication around cannabis use. The Scientific Committee has analyzed the results and developed a workshop around BI, adapted to adolescents cannabis users.
CANABIC is a quantitative study to validate use of BI with cannabis users: a randomized controlled trial, clustered study, comparing an intervention group (IG) and a control group (CG). The intervention is the achievement of the IB during a specific consultation. The outcome is the consumption of cannabic (Number of joints / month).
The study will be carried out in 3 french regions : Auvergne, Rhône-Alpes and Languedoc-Roussillon. 150 GPs wil be recruited and randomized in intervention group or control group (ratio 1 :1).
Each GP will inlcude 5 adolescents (i.e. a total of 750 adolescents) - . The number of adolescents needed has been calculate with hypothesis of a significant difference of 30% in consumption of cannabis between adolescents who beneficied of BI (IG) and those who do not experienced BI ( CG) A pilot study has been conducted. Cannabis use by adolescents has decreased. Their perception of cannabis has changed: they are aware of the harmful effects of their consumption. This pilot study has improve many points of the protocol.
Results:
A decrease of 30% of consumption is expected (joints per month). Perception of cannabis by adolescents will be reviewed.
Conclusions:
To validate an IB adaptated to consultation with adolscents cannabis consumer in order to provide a tool for GP in their daily practice.
Study Overview
Status
Intervention / Treatment
Detailed Description
General organisation of the study
- Recruitment of the GP: 3 months (from December 2011 to March 2012)
- Training of the intervention group GP during a one-day training, in March 2012, on 3 thematic: relationship between GP and adolescent, cannabis and BI; by an expert team
- Inclusion period : 10 months (from April 2012 to January 2013). The included patients will be followed for 12 months. There are 3 follow up consultations at 3, 6 and 12 months.
- First consultation used to the inclusion:
Information to the patient and collection of the patient non opposition (without informing the intervention objectives in the control group).
Evaluation of cannabis consumption, but also tobacco and alcohol consumption. Collection of the perception of cannabis by adolescents, and its impact on health.
Inclusion criteriae : repetead users : 1 to 10 per month; regular users : 11 to 29 per month; daily users : 1 and more per day.
In the IG : achievment of the BI with the adolescent. In each group, making appointment with the patient at 3 months
• Follow up consultations : At 3, 6 and 12 months. Evaluation of cannabis consumption, but also tobacco and alcohol consumption. Collection of the perception of cannabis by adolescents, and its impact on health.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Patrick LACARIN
- Phone Number: 04 73 75 1195
- Email: placarin@chu-clermontferrand.fr
Study Locations
-
-
-
Clermont-Ferrand, France, 63003
- Recruiting
- Chu Clermont-Ferrand
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adolescents 15 to 25 years Repetead users : 1 to 10 per month; regular users : 11 to 29 per month; daily users : 1 and more per day.
The patient must have given his informed consent and signed the form of no objection
Exclusion Criteria:
- Adolescents with psychiatric illness considered by the attending physician in acute decompensated
- Intellectual Disability
- Hard of hearing
- No French language skills
- Patient already under treatment for the withdrawal of an addicition to cannabis or other substance
- Adolescents who participated in the preliminary qualitative study
Study Plan
How is the study designed?
Design Details
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: control group
|
CANABIC is a quantitative study to validate use of BI with cannabis users: a randomized controlled trial, clustered study, comparing an intervention group (IG) and a control group (CG).
The intervention is the achievement of the IB during a specific consultation.
The outcome is the consumption of cannabic (Number of joints / month).
|
EXPERIMENTAL: intervention group
|
CANABIC is a quantitative study to validate use of BI with cannabis users: a randomized controlled trial, clustered study, comparing an intervention group (IG) and a control group (CG).
The intervention is the achievement of the IB during a specific consultation.
The outcome is the consumption of cannabic (Number of joints / month).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the number of joints consumed per month
Time Frame: at 12 months
|
at 12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the number of joints consumed per month
Time Frame: at 3 and at 6 months
|
at 3 and at 6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Catherine LAPORTE, MD, University Hospital, Clermont-Ferrand
Publications and helpful links
General Publications
- Laporte C, Lambert C, Pereira B, Blanc O, Authier N, Balayssac D, Brousse G, Vorilhon P. Cannabis users: Screen systematically, treat individually. A descriptive study of participants in a randomized trial in primary care. PLoS One. 2019 Dec 2;14(12):e0224867. doi: 10.1371/journal.pone.0224867. eCollection 2019.
- Laporte C, Vaillant-Roussel H, Pereira B, Blanc O, Eschalier B, Kinouani S, Brousse G, Llorca PM, Vorilhon P. Cannabis and Young Users-A Brief Intervention to Reduce Their Consumption (CANABIC): A Cluster Randomized Controlled Trial in Primary Care. Ann Fam Med. 2017 Mar;15(2):131-139. doi: 10.1370/afm.2003.
- Laporte C, Vaillant-Roussel H, Pereira B, Blanc O, Tanguy G, Frappe P, Costa D, Gaboreau Y, Badin M, Marty L, Clement G, Dubray C, Falissard B, Llorca PM, Vorilhon P. CANABIC: CANnabis and Adolescents: effect of a Brief Intervention on their Consumption--study protocol for a randomized controlled trial. Trials. 2014 Jan 30;15:40. doi: 10.1186/1745-6215-15-40.
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHU-0103
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Health Care
-
Veteran Affairs Office of Patient Care ServicesVA Office of Research and Development; VA Palo Alto Health Care System; VHA Primary...CompletedPrimary Health Care | Health Care CostsUnited States
-
Veteran Affairs Office of Patient Care ServicesVA Office of Research and Development; VA Palo Alto Health Care System; VHA Primary...CompletedPrimary Health Care | Health Care Costs
-
VA Office of Research and DevelopmentVA Palo Alto Health Care System; Veteran Affairs Office of Patient Care ServicesCompletedPrimary Health Care | Health Care Costs
-
University of CoimbraCompletedPalliative Care | Primary Health CarePortugal
-
Bert LeysenIntermutualistic Agency; National Institute for Health and Disability Insurance...CompletedPalliative Care | Primary Health CareBelgium
-
Wellington-Dufferin-Guelph Public HealthBoston Medical Center; University of Guelph; East Wellington Family Health Team; Minto-Mapleton Family Health Team and other collaboratorsCompletedPrimary Health Care | Health Information Technology | Risk Assessment | Preconception CareCanada
-
University of Colorado, DenverCompletedPrimary Health Care | Advance Care PlanningUnited States
-
Oregon Health and Science UniversityCompletedPrimary Health Care | Health Services | ComorbidityUnited States
-
Université de SherbrookeIsabelle Gaboury; Mike Green; Tara Kiran; Janusz Kaczorowski; Maude LabergeRecruiting
-
The University of Hong KongCompleted
Clinical Trials on Brief Intervention
-
i4HealthTerminated
-
New York State Psychiatric InstituteNot yet recruitingDepression | Mental Health Disorder | Adolescent Behavior | Stigma, SocialUnited States
-
University of Texas at AustinNational Institute on Drug Abuse (NIDA)Completed
-
Friends Research Institute, Inc.National Institute on Drug Abuse (NIDA)CompletedDrug Abuse | HIV Risk BehaviorUnited States
-
Wayne State UniversityNational Institute on Drug Abuse (NIDA)Completed
-
Friends Research Institute, Inc.National Institute on Drug Abuse (NIDA)CompletedRisk Behavior | Marijuana Use | Alcohol Consumption | Unsafe Sex
-
New York State Psychiatric InstituteNot yet recruitingDepression | Mental Health Disorder | Stigma, SocialUnited States
-
University of California, San FranciscoCompletedMetabolic HealthUnited States
-
University of MichiganNational Institute on Drug Abuse (NIDA)CompletedDrug Use | Sex BehaviorUnited States
-
University of Dublin, Trinity CollegeCompletedSpondylitis, AnkylosingIreland